Nopras Technologies, Inc. Expands into Southeast Asia
September 1, 2010
Nopras Technologies, Inc opens a strategic office in Singapore to help address the unmet challenging needs of global pharmaceutical, biotech/biologics and medical device companies in Asia. Nopras Singapore Pte. Ltd is uniquely positioned to tap into Asia’s growth of pharmaceutical, biotech/biologics and medical device operations.
“Our mission is to continue to help our clients in the region make better decisions faster, which has become even more important in these tough economic times” says Carla Glaze, President.
We are continually striving to improve our service offerings in line with this mission, and this endeavor was no different. Thanks to a great deal of customer feedback we will be offering some new innovative solutions and major new services. We will be launching Nopras University, a new on-line training facility containing self paced learning courses for our services and their application in key methodologies like Lean Six Sigma.
We are listening, so please continue to share your thoughts with us and we will continue to improve our services to help meet your goals.
About Nopras Technologies, Inc.
Nopras Technologies has worked with clients globally in creating value to solve most difficult technical, quality, regulatory and compliance problems to advance new and existing medicines that improve human health. This success is based on our consultants’ abilities to provide industry expertise covering a wide range of technical disciplines, grown from a solid base of scientific and engineering fundamental understanding.
The company provides a broad spectrum of Regulatory, Compliance and Quality Services, Operational Improvement and Technical Services, Turnkey Solutions Services (Facility Start-Up and New Product Launch).
Its service portfolio covers FDA and foreign regulations/ guidelines and spans the full product development life cycle; from clinical development through market scrutiny.
The firm’s staff consists of well-credentialed physicians, scientists, engineers, and technical experts from industry leaders with extensive business and industry experience; many of whom are key opinion leaders, have held key management positions and have earned advanced degrees in medicine, science, engineering and business operate as a working team to integrate the different skill sets they offer.
Nopras Technologies assists clients’ advance promising drug candidates from conception through commercialization by providing technical, quality and regulatory support, assisting in process development and optimization, and manufacturing clinical-trial quantities of drug candidates and regulatory submissions.
The company is based in Novi, MI with offices in Fort Washington, PA, Shanghai, China and Singapore. For more information, visit www.nopras-tech.com.